Get Premium

Get Premium

Dominate Financial Markets with Stock Target Advisor Premium Features

Discover
Discover

Explore new stock opportunities and market trends for better investment decisions.
- Analyst Ratings & Stock Picks
- Top Picks By AI
- Latest Analyst Ratings
- Analyst Directory
- Worst Stocks
- Sector Ratings & Performance
- Smart Filters
- Best Penny Stocks
- Best Dividend Stocks
- Best Crypto Stocks
- Best Performing Stocks
- Worst Performing Stocks
- Highest Income ETFs
Research
Research

Access in-depth stock analysis and expert evaluations to guide your investments
- Automatic Selection
- Stocks/ETF Screener
- Query Builder
- Analyst Screener
- Automated Research Reports
- Best Stocks Filters
- Thematic Stock Screens
- Sector Stock Screens
Learn
Learn

Utilize our extensive educational resources designed to enhance your investing knowledge and skills
- Market News & Insights
- Stock Target Advisor Insights
- Tutorials
- Market News
- Stock Calendars
- Earnings Calendar
- IPO Calendar
- Splits Calendar
Watchlists & Portfolios
Watchlists & Portfolios

Easily manage, track, and optimize your stock selections for maximum returns
Engage
Engage

Connect with the investing community and access free widgets for better stock insights
Pricing

Guessing Isn’t a Strategy!

Use Research That Shows You What to Buy, When to Buy, and Why—Now Upto 70% OFF! Claim Now

CorMedix Inc (CRMD) Stock Analyst Ratings & Price Targets

COMMON STOCK | Biotechnology | NSD

Target Add to Watchlist

Take a Tour

Strong Buy

Average Analyst
Rating

Slightly Bearish

Stock Target Advisor
Analysis

N/A

Average User
Rating

Last Closing Price

USD 9.15

Change

+0.70 (+8.28%)

Market Cap

USD 0.45B

Volume

1.01M

Avg User Target

N/A

CRMD

CorMedix Inc (USD)

COMMON STOCK | NSD

USD 9.15

+0.70 ( +8.28%)

Watchlist

CorMedix Inc (CRMD) Stock Forecast

Show ratings and price targets of :

All Analysts

Top Analysts

Average Analyst Target

USD 16.18

(+76.85%)

Based on the CorMedix Inc stock forecast from 6 analysts, the average analyst target price for CorMedix Inc is USD 16.18 over the next 12 months. CorMedix Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of CorMedix Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, CorMedix Inc’s stock price was USD 9.15. CorMedix Inc’s stock price has changed by +19.30% over the past week, -15.04% over the past month and +71.67% over the last year.

Analyst Ratings

Filter:

Show:

Target Price Action	Rating Action	Analyst	Rating	Price	Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What not to like

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.